Page last updated: 2024-08-23

fenticonazole and fluconazole

fenticonazole has been researched along with fluconazole in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Alexopoulos, EC; Antonopoulou, S; Aoun, M; Baka, S; Grigoriou, O; Kalambokas, T; Kouskouni, E; Logothetis, E; Papadias, K; Velegraki, A; Zannos, A1
Kovachev, S; Nacheva, A; Vacheva-Dobrevska, R; Vasilev, N1
Di Francesco, S; Felice, R; Graziottin, A; Mantegazza, V; Murina, F1
Helou, J; Maatouk, I; Moutran, R; Obeid, G1
Chen, H; Fang, F; Feng, D; Mei, L; Wang, X; Wei, DM; Xie, HY1
Cacaci, M; Menchinelli, G; Posteraro, B; Sanglard, D; Sanguinetti, M; Torelli, R1

Reviews

1 review(s) available for fenticonazole and fluconazole

ArticleYear
Probiotics for vulvovaginal candidiasis in non-pregnant women.
    The Cochrane database of systematic reviews, 2017, 11-23, Volume: 11

    Topics: Administration, Intravaginal; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Fluconazole; Humans; Imidazoles; Miconazole; Probiotics; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention

2017

Trials

1 trial(s) available for fenticonazole and fluconazole

ArticleYear
[Short-course treatment of vulvovaginal candidiasis: comparative study of fluconazole and intra-vaginal fenticonazole].
    Minerva ginecologica, 2012, Volume: 64, Issue:2

    Topics: Administration, Intravaginal; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Administration Schedule; Female; Fluconazole; Humans; Imidazoles; Prospective Studies; Time Factors; Treatment Outcome

2012

Other Studies

4 other study(ies) available for fenticonazole and fluconazole

ArticleYear
Fenticonazole activity measured by the methods of the European Committee on Antimicrobial Susceptibility Testing and CLSI against 260 Candida vulvovaginitis isolates from two European regions and annotations on the prevalent genotypes.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Adult; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Cluster Analysis; DNA Fingerprinting; Drug Resistance, Fungal; Europe; Female; Fluconazole; Genotype; Humans; Imidazoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Prevalence

2009
[Combined single-day treatment in acute vulvovaginal candidosis].
    Akusherstvo i ginekologiia, 2009, Volume: 48, Issue:6

    Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Drug Therapy, Combination; Female; Fluconazole; Humans; Imidazoles

2009
Pityriasis versicolor: a case of resistance to treatment.
    International journal of dermatology, 2014, Volume: 53, Issue:2

    Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Middle Aged; Naphthalenes; Recurrence; Terbinafine; Tinea Versicolor; Treatment Failure

2014
New Data on the
    Antimicrobial agents and chemotherapy, 2020, 11-17, Volume: 64, Issue:12

    Topics: Antifungal Agents; Candida; Drug Resistance, Fungal; Fluconazole; Imidazoles; Microbial Sensitivity Tests

2020